Durvalumab

Immunoglobulin G1, anti-(human CD antigen CD274) (human monoclonal MEDI4736 heavy chain), disulfide with human monoclonal MEDI4736 kappa-chain, dimer

Stoffgruppe

Antineoplastisches Mittel (Checkpoint-Inhibitor)